Surmodics (SRDX) executive Olson gave up 1,534 shares at $39.45 to cover taxes or an exercise price
Insider transactions reported
Charles W Olson (SVP, Medical Device Coatings at Surmodics Inc., SRDX) reported that they gave up 1,534 shares at $39.45 to cover taxes or an exercise price on Nov 30, 2024. After these transactions the filing shows 52,437 shares held directly.
- Reporting person
- Olson Charles W
- Role
- SVP, Medical Device Coatings
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 30, 2024 | Shares withheld for taxes or exercise price (F) | Common Stock | -1,534 | $39.45 | $60.5K | 52,437 direct |
Holdings before and after
- Common Stock: 53,971 to 52,437 direct
Other positions listed
- Common Stock: 800 indirect, By IRA
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Olson report in this SRDX Form 4?
Charles W Olson (SVP, Medical Device Coatings at Surmodics Inc., SRDX) reported that they gave up 1,534 shares at $39.45 to cover taxes or an exercise price on Nov 30, 2024. After these transactions the filing shows 52,437 shares held directly.
How many SRDX shares does Olson hold after this filing?
The filing shows 52,437 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for SRDX
Earlier insider filings at SRDX
- Dec 3, 2024President & CEO Maharaj Gary R covered exercise/tax liability with 6,470 shares, decreasing direct ownership by 3% to 196,304 units (SEC Form 4)
- Dec 3, 2024VP Finance, Corp. Controller Manders John D. covered exercise/tax liability with 387 shares, decreasing direct ownership by 4% to 8,307 units (SEC Form 4)
- Dec 3, 2024SVP of HR, President IVD Stich Joseph J. covered exercise/tax liability with 1,655 shares, decreasing direct ownership by 3% to 62,665 units (SEC Form 4)
- Dec 3, 2024SVP, Vascular Interventions Sides Teri Woodwick covered exercise/tax liability with 1,312 shares, decreasing direct ownership by 4% to 35,649 units (SEC Form 4)
- Nov 27, 2024Chief Financial Officer Arens Timothy J. sold $276,453 worth of shares (7,009 units at $39.44), decreasing direct ownership by 9% to 70,350 units (SEC Form 4)
Keep researching SRDX
- SRDX insider tradesEvery buy and sale reported by Surmodics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 1998
Follow SRDX and get a push notification the moment its next story breaks.